Literature DB >> 21477686

Predictors of pregnancy in microbicide trials.

Vera Halpern1, Che-Chin Lie, Paul Feldblum, Lut Van Damme.   

Abstract

BACKGROUND: High pregnancy rates undermine the conduct and interpretation of HIV prevention trials. We performed this analysis to identify baseline participant characteristics associated with increased risk of pregnancy in recent vaginal microbicide trials. STUDY
DESIGN: We analyzed the data from four recently completed Phase III trials of candidate microbicides for prevention of HIV infection. Cox proportional hazard models, stratified by site nested within study, were used to determine the baseline factors that predict pregnancy. Six thousand seven hundred forty-eight women contributed data for this analysis.
RESULTS: Pregnancies were detected in a total of 1826 (27.1%) women. The hazard of pregnancy was higher for women who had a history of pregnancy, were living with a man or reported more sexual acts not protected by condoms in the week prior to enrollment. The risk of pregnancy was lower in older participants; in women with more years of education; in women who reported more sexual partners at baseline interview; in women who reported using intrauterine contraception, implants, sterilization or injectables and in women who reported use of a condom during their last act of vaginal intercourse.
CONCLUSIONS: Our data suggest that current use or acceptance of intrauterine contraception, implants, sterilization or injectables is the most effective approach to reduce pregnancy rates and might be a useful eligibility criterion in future HIV prevention trials.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21477686     DOI: 10.1016/j.contraception.2010.08.018

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  12 in total

1.  Contraception and pregnancy in microbicide trials.

Authors:  Sengeziwe Sibeko; Gabriel M Cohen; Jagidesa Moodley
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2012-03-03       Impact factor: 5.237

2.  Ethical issues for late-stage trials of multipurpose prevention technologies for HIV and pregnancy.

Authors:  Jessica A Cohen; Anna C Mastroianni; Ruth Macklin
Journal:  Int J Gynaecol Obstet       Date:  2014-07-22       Impact factor: 3.561

3.  Contraceptive method and pregnancy incidence among women in HIV-1-serodiscordant partnerships.

Authors:  Kenneth Ngure; Renee Heffron; Nelly R Mugo; Connie Celum; Craig R Cohen; Josephine Odoyo; Helen Rees; James N Kiarie; Edwin Were; Jared M Baeten
Journal:  AIDS       Date:  2012-02-20       Impact factor: 4.177

4.  Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial.

Authors:  Carolyne A Akello; Katherine E Bunge; Clemensia Nakabiito; Brenda G Mirembe; Mary Glenn Fowler; Anupam Mishra; Jeanne Marrazzo; Zvavahera M Chirenje; Connie Celum; Jennifer E Balkus
Journal:  J Womens Health (Larchmt)       Date:  2017-02-17       Impact factor: 2.681

5.  Pregnancy and contraceptive use among women participating in an HIV prevention trial in Tanzania.

Authors:  Aderonke Odutola; Kathy Baisley; Richard J Hayes; Mary Rusizoka; Clare Tanton; Helen A Weiss; John Changalucha; David A Ross; Deborah Watson-Jones
Journal:  Sex Transm Infect       Date:  2012-03-21       Impact factor: 3.519

6.  Pregnancy incidence and correlates during the HVTN 503 Phambili HIV vaccine trial conducted among South African women.

Authors:  Mary H Latka; Katherine Fielding; Glenda E Gray; Linda-Gail Bekker; Maphoshane Nchabeleng; Koleka Mlisana; Tanya Nielson; Surita Roux; Baningi Mkhize; Matsontso Mathebula; Nivashnee Naicker; Guy de Bruyn; James Kublin; Gavin J Churchyard
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

7.  High medication adherence during periconception periods among HIV-1-uninfected women participating in a clinical trial of antiretroviral pre-exposure prophylaxis.

Authors:  Lynn T Matthews; Renee Heffron; Nelly R Mugo; Craig R Cohen; Craig W Hendrix; Connie Celum; David R Bangsberg; Jared M Baeten
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

8.  Women with pregnancies had lower adherence to 1% tenofovir vaginal gel as HIV preexposure prophylaxis in CAPRISA 004, a phase IIB randomized-controlled trial.

Authors:  Lynn T Matthews; Sengeziwe Sibeko; Leila E Mansoor; Nonhlanhla Yende-Zuma; David R Bangsberg; Quarraisha Abdool Karim
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

Review 9.  Pregnancy incidence and risk factors among women participating in vaginal microbicide trials for HIV prevention: systematic review and meta-analysis.

Authors:  Alfred Musekiwa; Evans Muchiri; Samuel O M Manda; Henry G Mwambi
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

10.  Pregnancy incidence and correlates in a clinical trial preparedness study, North West Province South Africa.

Authors:  Candice M Chetty-Makkan; Katherine Fielding; Paul J Feldblum; Matt A Price; Petra Kruger; Heeran Makkan; Salome Charalambous; Mary H Latka
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.